Pfizer, Voyager Therapeutics ink USD 630 million gene therapy deal
Under the terms of the agreement, Pfizer will have the right to evaluate novel capsids selected for central nervous system and cardiac tropisms from Voyager's TRACER platform and to exercise options...
Source: medicaldialogues.in